NLRP3 Inflammasome Links Gum Disease Severity to Inflammaging
A completed trial examines how a key inflammation pathway connects periodontitis stages to the chronic low-grade inflammation of aging.
41 articles in this topic
A completed trial examines how a key inflammation pathway connects periodontitis stages to the chronic low-grade inflammation of aging.
The landmark Phase 1/2/3 trial that brought mRNA COVID-19 vaccination to the world, now completed with booster and variant data.
A terminated RCT explored whether immunotype-targeted supplements could reduce iAge®, an AI-derived biomarker of chronic inflammation and immune aging.
A Phase 3 trial evaluates a next-generation quadrivalent influenza vaccine against existing options, testing both immune response and manufacturing consistency.
A completed Phase 2 trial investigates the immune mechanisms behind age-related vaccine failure in older adults.
A Phase 2 pilot trial investigates whether the natural senolytic compound fisetin can reduce dysfunction and complications in COVID-19 patients.
A completed RCT from the University of Copenhagen tests whether aerobic exercise, time-restricted feeding, or NR supplementation best improves biological aging markers in healthy older adults.
28-day trial of 108 participants found specific breathing techniques outperformed mindfulness meditation for stress reduction and wellbeing.
Study explores whether telomere biology and senescence biomarkers can forecast acute kidney injury following cardiac procedures.
8-week stress management program shows promise for reducing inflammation and improving well-being in aging adults through mindfulness techniques.
Researchers tested sirolimus, metformin, and diclofenac as topical skin treatments to target aging pathways in healthy volunteers.
Small pilot study tests whether acarbose, a diabetes medication, can slow aging processes in healthy older adults through microbiome changes.